Vivek Nagaraja (@vivnag) 's Twitter Profile
Vivek Nagaraja

@vivnag

Rheumatology Division Chair, @MayoClinic Arizona | Researcher #rheumatology #MayoClin, @scleroderma, @ILD. All tweets are my own.

ID: 75904385

calendar_today20-09-2009 23:38:36

168 Tweet

615 Followers

588 Following

Ashima Makol MD (@ashimamakol) 's Twitter Profile Photo

With Molecular profiling, 2 FDA approved Tx & 💪pipeline of Novel 💊we’ve come a LONG way.. Excited & Honored to moderate this years Philip S. Hench,MD,Memorial Lecture American College of Rheumatology! ✨#SCLERODERMA 2022:Moving to Precision Management✨by Dr. Fredrick Wigley #ACR22 #ACRambassador

With Molecular profiling, 2 FDA approved Tx & 💪pipeline of Novel 💊we’ve come a LONG way..

Excited &amp; Honored to moderate this years Philip S. Hench,MD,Memorial Lecture <a href="/ACRheum/">American College of Rheumatology</a>!

✨#SCLERODERMA 2022:Moving to Precision Management✨by Dr. Fredrick Wigley 

#ACR22 #ACRambassador
Vivek Nagaraja (@vivnag) 's Twitter Profile Photo

4-days to go! 6th session Mayo Clinic #Telehealth in #Rheumatology webinar Empowering Scleroderma Patients through Digital Health Interventions. By Dr. Susan Murphy, ScD, OTR University of Michigan December 14, 2023 11:30 AM CT Free Registration mc-meet.zoom.us/webinar/regist…

4-days to go! 

6th session <a href="/MayoClinic/">Mayo Clinic</a> #Telehealth in #Rheumatology webinar

Empowering Scleroderma Patients through Digital Health Interventions. 

By Dr. Susan Murphy, ScD, OTR <a href="/UMich/">University of Michigan</a> 

December 14, 2023
11:30 AM CT

Free Registration mc-meet.zoom.us/webinar/regist…
Bart Demaerschalk MD FRCPC Co-PI NIH TELENEO Trial (@demaerschalk) 's Twitter Profile Photo

The inaugural Mayo Clinic #DigitalHealth Research Symposium will occur on 3/20/24 from 12-2pm CDT. This free virtual event will feature panel discussions & presentations about how digital solutions are transforming healthcare. Reserve your seat here ➡️ surveys.mayoclinic.org/jfe/form/SV_6e…

Vivek Nagaraja (@vivnag) 's Twitter Profile Photo

7th session Mayo Clinic #Telehealth in #Rheumatology webinar Digital Technologies to Support Clinical Care and Real-World Data Generation By Jeffrey R Curtis, MD MS MPH Jeffrey Curtis February 21, 2024, 11:30 a.m.-12:30 p.m. CT Free Registration mc-meet.zoom.us/webinar/regist…

7th session
<a href="/MayoClinic/">Mayo Clinic</a> #Telehealth in #Rheumatology webinar

Digital Technologies to Support Clinical Care and Real-World Data Generation

By Jeffrey R Curtis, MD MS MPH <a href="/RADoctor/">Jeffrey Curtis</a> 

February 21, 2024, 11:30 a.m.-12:30 p.m. CT

Free Registration mc-meet.zoom.us/webinar/regist…
Vivek Nagaraja (@vivnag) 's Twitter Profile Photo

Systemic sclerosis with morphea-like plaques histopathologically mimic... sciencedirect.com/science/articl… A unique case of systemic sclerosis with co-existent morphea like plaques and surprising histopathology. Thanks to Ana Aragon-Sierra, David DiCaudo, and Aaron Mangold Mayo Clinic

Vivek Nagaraja (@vivnag) 's Twitter Profile Photo

Our latest review on what role the imaging innovations may play in the future in CTD-ILDs (aka SARD-ILD). Thanks to Mayo Clinic & UAzPACCS team Clint Jokerst, Sachin Chaudhary Ana Zamora, and Kavitha Yaddanapudi. It is an open access article. emjreviews.com/radiology/arti…

Vivek Nagaraja (@vivnag) 's Twitter Profile Photo

Delighted to share our comprehensive review on diagnostic approaches to #CTD-ILD (#SARD-ILD). An update for clinicians Thx to Mayo Clinic co-authors: Ana C. Zamora , Lewis Wesselius, Michael Gotway, Henry Tazelaar, and Alejandro Diaz thieme-connect.com/products/ejour…

Elena MyasoedovaMD ☀️ (@myasoedovaelena) 's Twitter Profile Photo

📣75th anniversary of cortisone discovery. 💊 This #wonderdrug is the legacy of #Mayoclinicrheumatology 📝a masterful article by #RheumGiants #DrMatteson and #DrHunder John M. Davis III, MD MS KenWarringtonMD Ashima Makol MD

NEJM Evidence (@nejmevidence) 's Twitter Profile Photo

“A potential explanation for differential access to CART19 among minoritized racial groups, particularly in highly resourced academic centers, is racial disparity in treatment recommendations.” Read the full editorial: eviden.cc/3TvT2n6

“A potential explanation for differential access to CART19 among minoritized racial groups, particularly in highly resourced academic centers, is racial disparity in treatment recommendations.” Read the full editorial: eviden.cc/3TvT2n6
Ashima Makol MD (@ashimamakol) 's Twitter Profile Photo

🙌 Proud of this tri-site participation from Mayo Clinic in ✨CONQUEST✨ 1st ever Global ‘Platform Clinical Trial’ in #Rheumatology funded by Scleroderma Research Foundation @SRFCure, that promises to accelerate drug development in #SclerodermaILD ! 👉 conquestssc-trial.org/conquest-study

🙌 Proud of this tri-site participation from <a href="/MayoClinic/">Mayo Clinic</a> in ✨CONQUEST✨

1st ever Global ‘Platform Clinical Trial’ in #Rheumatology funded by Scleroderma Research Foundation @SRFCure, that promises to accelerate drug development in #SclerodermaILD !

👉 conquestssc-trial.org/conquest-study
Vivek Nagaraja (@vivnag) 's Twitter Profile Photo

It was great to catch up with Dr. Dinesh Khanna Dinesh Khanna - a wonderful mentor and a dear friend. Thank you for all the guidance in shaping my career. #CONQUEST SRFCure

It was great to catch up with <a href="/sclerodermaUM/">Dr. Dinesh Khanna</a> Dinesh Khanna - a wonderful mentor and a dear friend. Thank you for all the guidance in shaping my career. #CONQUEST <a href="/srfcure/">SRFCure</a>
Dr. Dinesh Khanna (@sclerodermaum) 's Twitter Profile Photo

➡️srfcure.org/research/conqu… 📷Testing nerandomilast (PDE4 b inh) Boehringer Ingelheim and amlitelimab (anti OX 40L) Sanofi ➡️Phase 2b program ➡️ 150 sites in 25 countries

Annals of the Rheumatic Diseases (@eular_ard) 's Twitter Profile Photo

🙌Novel auto-antibody in #SSc 👉Anti-anti-PRMT5 antibodies ✅️correlated with progression in skin and lung ✅️distinguished SSc from healthy, lupus and Sjögren’s syndrom ✅️induced SSc-like manifestations in mice ard.bmj.com/content/early/…

🙌Novel auto-antibody in #SSc 
👉Anti-anti-PRMT5 antibodies 
✅️correlated with progression in skin and lung 
✅️distinguished SSc from healthy, lupus and Sjögren’s syndrom 
✅️induced SSc-like manifestations in mice 
ard.bmj.com/content/early/…
NEJM Evidence (@nejmevidence) 's Twitter Profile Photo

A 59-year-old man initially had fevers and truncal rash; two weeks later, joint pain and bilateral hearing loss developed. What is the differential diagnosis? Read the Morning Report: eviden.cc/4exCNPt #MedTwitter Sarah Amjad Vivek Nagaraja Mayo Clinic Alix School of Medicine

A 59-year-old man initially had fevers and truncal rash; two weeks later, joint pain and bilateral hearing loss developed. What is the differential diagnosis? Read the Morning Report: eviden.cc/4exCNPt 

#MedTwitter <a href="/Sarahamjad_/">Sarah Amjad</a> <a href="/vivnag/">Vivek Nagaraja</a> <a href="/MayoClinicSOM/">Mayo Clinic Alix School of Medicine</a>
Vivek Nagaraja (@vivnag) 's Twitter Profile Photo

Pulmonary Rehabilitation has short-term benefits in CTD-ILD. See our latest article. A prospective study affected by the pandemic. Took 5-years and three journals to publish. journals.sagepub.com/doi/10.1177/09… Thanks to Dr. Dinesh Khanna, Rosemary Gedert, and team